Back to mobile site
Get it on Google Play

Conexeu Sciences targets Q1 2027 FDA 510(k) submission for wound device

October 6, 2026 8:30 AM EDT Send to a Friend
Conexeu Sciences Inc. (Nasdaq: CNXU), a preclinical-stage medical device company based in Reno, Nevada, said it remains on track to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login